(Total Views: 1061)
Posted On: 04/08/2020 4:52:05 PM
Post# of 148884
Suggestions For Future Interviews: Pivot, Pivot, and Pivot again.
As politicians do, any person being interviewed needs to script what he/she wants to say, and pivot from the question asked, and give such scripted answers.
In the four minutes he was interviewed by Charles Payne, Pourhassan could and should have been prepared to say, and pivoted to say:
1. 4 out of 9 seriously ill Covid-19 patients who were treated with Leronlimab at a leading New York City hospital, were able to be taken off of their ventilators after only three days.
2. The immune function in all 9 of these seriously ill Covid-19 patients was fully restored after 7 days, while their cytokine storms were reduced by between 70 and 90 percent.
3. The patients who improved greatly on Leronlimab had previously been treated, without success, on either hydroxychloride or remdesivir. In other words, these 9 patients had better results after being treated with Leronlimab than they had with either hydroxychloride or remdesivir.
4. In over 800 patients who have been treated with Leronlimab over the past five years for HIV and metastatic breast cancer, there has not been one serious adverse event attributable to this drug.
5. Leronlimab is now in two FDA approved clinical trials for mild to moderate, and seriously ill, Covid-19 patients. Cytodyn expects to have at least some results for these trials within 30 days.
If Pourhassan had made these comments, in response to whatever questions Payne offered, the viewers would have come away with a much more favorable impression of Leronlimab.
If someone knows Charles Payne, they might want to advise him of the above, so he would be able to ask questions that would be conducive to eliciting this information.
However, if the questions by Payne, or any future interviewer, are not phrased so as to elicit this information, Pourhassan must pivot, and provide this information, just as every politician pivots in responding to questions from reporters.
LM
As politicians do, any person being interviewed needs to script what he/she wants to say, and pivot from the question asked, and give such scripted answers.
In the four minutes he was interviewed by Charles Payne, Pourhassan could and should have been prepared to say, and pivoted to say:
1. 4 out of 9 seriously ill Covid-19 patients who were treated with Leronlimab at a leading New York City hospital, were able to be taken off of their ventilators after only three days.
2. The immune function in all 9 of these seriously ill Covid-19 patients was fully restored after 7 days, while their cytokine storms were reduced by between 70 and 90 percent.
3. The patients who improved greatly on Leronlimab had previously been treated, without success, on either hydroxychloride or remdesivir. In other words, these 9 patients had better results after being treated with Leronlimab than they had with either hydroxychloride or remdesivir.
4. In over 800 patients who have been treated with Leronlimab over the past five years for HIV and metastatic breast cancer, there has not been one serious adverse event attributable to this drug.
5. Leronlimab is now in two FDA approved clinical trials for mild to moderate, and seriously ill, Covid-19 patients. Cytodyn expects to have at least some results for these trials within 30 days.
If Pourhassan had made these comments, in response to whatever questions Payne offered, the viewers would have come away with a much more favorable impression of Leronlimab.
If someone knows Charles Payne, they might want to advise him of the above, so he would be able to ask questions that would be conducive to eliciting this information.
However, if the questions by Payne, or any future interviewer, are not phrased so as to elicit this information, Pourhassan must pivot, and provide this information, just as every politician pivots in responding to questions from reporters.
LM
(8)
(0)
The Lawmanstyle="color:red">The Lawman"color:red">The Lawman:red">The LawmanThe Lawmanspan>Lawmanawmanimg]
Scroll down for more posts ▼